The Week Ahead: Hom...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$4.74 -0.16 | -3.27%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 63.19M | 10.75M | 18.21M | 23.87M |
| Receivables | 520.81K | 101.13K | 633.22K | 1.27M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 63.94M | 11.08M | 19.08M | 25.43M |
| Property, Plant & Equipment, Gross | 4.37M | 5.43M | 5.12M | 5.01M |
| Accumulated Depreciation & Depletion | 1.53M | 2.14M | 1.69M | 1.27M |
| Property, Plant & Equipment, Net | 2.84M | 3.29M | 3.42M | 3.74M |
| Intangibles | 6.18M | 6.15M | 7.04M | 7.13M |
| Other Non-Current Assets | 72.28K | 410.52K | 1.32M | 660.58K |
| Total Non-Current Assets | 11.80M | 12.56M | 14.50M | 14.25M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 75.74M | 23.65M | 33.58M | 39.68M |
| Accounts Payable | 10.76M | 5.09M | 4.66M | 6.57M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 4.50M | 279.30K | 4.99M | 5.29M |
| Total Current Liabilities | 23.24M | 17.88M | 22.14M | 23.62M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.72M | 1.65M | 1.66M | 1.60M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.72M | 1.65M | 1.66M | 1.60M |
| Total Liabilities | 25.96M | 19.52M | 23.79M | 25.22M |
| Preferred Stock Equity | 2.71K | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 49.77M | 4.12M | 9.79M | 14.46M |
| Common Par | 37.50K | 29.58K | 24.04K | 21.18K |
| Additional Paid In Capital | 143.70M | 99.71M | 82.06M | 73.70M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -93.92M | -95.57M | -72.25M | -59.21M |
| Treasury Stock | -47.18K | -47.18K | -47.18K | -47.18K |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 49.78M | 4.12M | 9.79M | 14.46M |
| Total Equity | 49.78M | 4.12M | 9.79M | 14.46M |
| Total Liabilities & Stock Equity | 75.74M | 23.65M | 33.58M | 39.68M |
| Total Common Shares Outstanding | 37.48M | 29.56M | 24.02M | 21.17M |
| Preferred Shares | 2.71M | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 15.49K | 15.49K | 15.49K | 15.49K |
| Basic Weighted Shares Outstanding | 30.55M | 28.32M | 23.15M | 20.22M |
| Diluted Weighted Shares Outstanding | 30.69M | 28.32M | 23.15M | 21.50M |
| Number of Employees | 21 | 17 | 20 | 16 |
| Number of Part-Time Employees | 0 | 1 | 1 | 1 |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
Latest BDSI Headlines from TheStreet
- BDSI Makes Notable Cross Below Critical Moving Average 05.17.13 | 11:05 am
- 2 Biotech Stocks Under $10 to Watch 04.11.13 | 02:04 pm
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- 3 Highly Shorted Stocks Under $5 Being Bought By Hedge Funds 02.01.13 | 01:02 pm
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 11.28.12 | 04:11 am
- 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook 11.27.12 | 06:11 am
- 5 Stocks Under $10 Soaring Higher 09.13.12 | 02:09 pm
- BioDelivery Sciences International Inc. Stock Upgraded (BDSI) 06.06.12 | 05:06 am
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am
Press Releases for BDSI
- BioDelivery Sciences Expands Product Pipeline With Acquisition Of Patented Topical Clonidine Gel For The Treatment Of Painful Diabetic Neuropathy - PR Newswire 03.26.13 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its 2012 Annual Report - PR Newswire 03.18.13 | 04:03 pm
- BioDelivery Sciences To Present At The 25th Annual ROTH Conference - PR Newswire 03.13.13 | 07:03 am
- BioDelivery Sciences To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 08:03 am
- INVESTOR ALERT: Former Attorney General Of Louisiana And Kahn Swick & Foti, LLC Investigate BioDelivery Sciences International, Inc., Following Notice Of Non-Reliance Of Financial Statements And Restatement - Business Wire 02.28.13 | 11:02 pm
- BioDelivery Sciences To Host Buprenorphine Investor And Analyst Event - PR Newswire 02.27.13 | 07:02 am
- BioDelivery Sciences To Present At The 15th Annual BIO CEO And Investor Conference - PR Newswire 02.05.13 | 07:02 am
- BioDelivery Sciences Announces Completion Of BNX Safety Study - PR Newswire 01.22.13 | 07:01 am
- BioDelivery Sciences Announces Hiring Of George Ng As General Counsel - PR Newswire 12.17.12 | 07:12 am
- BioDelivery Sciences Announces $40 Million Registered Financing - PR Newswire 11.28.12 | 07:11 am
Partner Headlines for BDSI
- 5 Medical Stock Losers From Last Week With High Short Ratios - Seeking Alpha 12.22.12 | 06:12 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.13.12 | 09:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 10.22.12 | 09:10 am
- Pipeline Progress at BioDelivery - Analyst Blog - NASDAQ 08.24.12 | 09:08 pm
- Pipeline Progress at BioDelivery - Analyst Blog - Zacks 08.24.12 | 05:08 pm
- Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX - GuruFocus 07.17.12 | 01:07 pm
- A Closer Look at Shares Getting New Coverage Today - Wall St. Cheat Sheet 07.03.12 | 02:07 am
- Best Performing Stocks At 2012's Midpoint - Seeking Alpha 06.29.12 | 07:06 pm
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
